Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of Fexofenadine 180 mg tablets vs Telfast 180 mg tablets in healthy Thai volunteers under fasting conditions
TCTR20230915004Phase 1Unknown
- Sponsor
- Bio-innova
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of antihistamine (TDDS/ODF) and fexofenadine in allergic rhinitis (AR) and chronic idiopathic urticaria (CIU) (2 arms), sponsored by Bio-innova. Status: unknown.
02
Drugs
antihistamine (TDDS/ODF)fexofenadine
03
Conditions
allergic rhinitis (AR)chronic idiopathic urticaria (CIU)
Beyond the preview
Go deeper on TCTR20230915004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230915004.